AffiliationCRC Department of Epithelial Biology, Paterson Institute for Cancer Research and Department of Surgery, Christie Hospital NHS Trust, Wilmslow Road, Manchester, UK.
MetadataShow full item record
AbstractStem cell research provides a foundation for therapeutic advancement in oncology, clinical genetics and a diverse array of degenerative disorders. For example, the elucidation of pathways governing proliferative regulation and differentiation within cellular systems will result in medical strategies aimed at the root cause of cancer. At present the characterization of reliable stem cell markers is the immediate aim in this particular field. Over the past 30 years investigators have determined many of the physical and functional properties of stem cells through careful and imaginative experimentation. Intestinal stem cells reside at the crypt base and give rise to all cell types found within the crypt. They readily undergo altruistic apoptosis in response to toxic stimuli although their progeny are hardier and will regain stem cell function to repopulate the tissue compartment, giving rise to the concept of a proliferative hierarchy. Contention exists when deciding whether the full complement of cells within a crypt is derived from either a single or multiple stems. Evidence has also arisen to challenge the long held view that colorectal tumours arise from a single mutated stem cell, as early adenomas from a human XO/XY mosaic contained distinct clones. Mechanisms governing the stem cell cycle and subsequent proliferative activity largely remain obscure. The adenomatous polyposis coli gene product has, however, been shown to promote the degradation of beta-catenin, an enhancer of cell proliferation, thereby downregulating this activity in healthy individuals.
CitationStem cells: the intestinal stem cell as a paradigm. 2000, 21 (3):469-76 Carcinogenesis
- [COX-2 associated loss of apoptosis activity in intestinal neoplams in Apc gene knock-out mice].
- Authors: Schmehl K, Jacobasch G, Buhr HJ
- Issue date: 1998
- Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population.
- Authors: Boman BM, Walters R, Fields JZ, Kovatich AJ, Zhang T, Isenberg GA, Goldstein SD, Palazzo JP
- Issue date: 2004 Nov
- Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level.
- Authors: Hsi LC, Angerman-Stewart J, Eling TE
- Issue date: 1999 Nov
- Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
- Authors: Keller JJ, Offerhaus GJ, Drillenburg P, Caspers E, Musler A, Ristimäki A, Giardiello FM
- Issue date: 2001 Dec
- Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam.
- Authors: Dobbie Z, Muller PY, Heinimann K, Albrecht C, D'Orazio D, Bendik I, Müller H, Bauerfeind P
- Issue date: 2002 Jul-Aug